Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Required for MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) activation during gastrulation (By similarity). Additionally we are shipping Suppressor of Ty 20 Homolog (S. Cerevisiae) Proteins (3) and many more products for this protein.
Showing 10 out of 20 products:
Both p38 (show CRK Antibodies) and p38IP are required for E-cadherin (show CDH1 Antibodies) downregulation during gastrulation. Also, p38 (show CRK Antibodies) regulates E-cadherin (show CDH1 Antibodies) protein expression downstream from NCK-interacting kinase (show MAP4K4 Antibodies).
p38IP inhibits ubiquitination-induced GCN5 (show KAT2A Antibodies) degradation and therefore promotes alpha-tubulin (show TUBA4A Antibodies) acetylation, facilitating spindle formation and G2/M progression.
hSPT20 and other hSAGA subunits, together with RNA polymerase II, are specifically recruited to genes induced by endoplasmic reticulum (ER) stress.
Manipulation of p38IP and p38alpha (show MAPK14 Antibodies) alters mAtg9 (show ATG9A Antibodies) localization, suggesting p38alpha (show MAPK14 Antibodies) regulates, through p38IP, the starvation-induced mAtg9 (show ATG9A Antibodies) trafficking to forming autophagosomes.
Novel transcription factors identified in human CD34 antigen (show CD34 Antibodies)-positive hematopoietic stem cells.
C13orf19 mRNA is down-regulated in matched prostate tissues compared to prostate carcinoma tissues
C13orf19 is expressed independently of the androgen. No interaction between C13orf19 and p38MAPK (show MAPK14 Antibodies) was identified.
mRNA is down-regulated in human prostate cancer, also described as C13
Required for MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) activation during gastrulation (By similarity).
, transcription factor SPT20 homolog
, family with sequence similarity 48, member A
, p38 interacting protein
, p38-interacting protein
, transcription factor (p38 interacting protein)
, tumor rejection antigen